Could the addition of hp-hMG and GnRH antagonists modulate the response in IVF-ICSI cycles?

Human Fertility

Volumn 13, Issue 1, 2010, Pages 41-49

  Requena, Antonio ^a   Landeras, José L ^b   Martínez Navarro, Luis ^c   Calatayud, Carmen ^d   Sánchez, Fernando ^e   Maldonado, Vicente ^f   Muñoz, Manuel ^g   Fernández, Manuel ^h   González, Alejandro ⁱ   López, Setefilla ^c   López, Rocío ^c   Pacheco, Alberto ^j   Calderón, Gloria ^k   Martínez, Vicente ^l  

^a IVI Madrid   (Spain)

^b IVI Murcia   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d Instituto CREA   (Spain)

^e Assisted Reproduction Centre   (Spain)

^f Hosp Univ Ciudad de Jaén   (Spain)

^g IVI Alicante   (Spain)

^h IVI Sevilla   (Spain)

ⁱ Instituto Medico Serman   (Spain)

^j Andrology and General Laboratory   (Spain)

^k Andrology and IVF Laboratory   (Spain)

^l UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

more..

Author keywords

Embryo quality; GnRH antagonist; Highly purified menotrophin; Ovulation induction; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; DROSPIRENONE PLUS ETHINYLESTRADIOL; GANIRELIX; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; OVULATION INDUCTION; PARALLEL DESIGN; PREGNANCY RATE;

EID: 77951004876     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.3109/14647270903586356     Document Type: Article

References (32)

1. Al-Inany, H. G., Abou-Setta, A. M., &Aboulghar, M. (2006). Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database of Systematic Reviews, 19, CD001750.
2. Andersen, A. N., Devroey, P., &Arce, J. C. (2006). Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Human Reproduction, 21, 3217-3227. (Pubitemid 44811626)
3. Andersen, A. N., Goossens, V., Ferraretti, A. P., Bhattacharya, S., Felberbaum, R., de Mouzon, J., Nygren, K. G.; European IVF-monitoring (EIM) Consortium; &European Society of Human Reproduction and Embryology (ESHRE). (2008). Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Human Reproduction, 23, 756-771. (Pubitemid 40790238)
4. Arce, J. C., Nyboe Andersen, A., &Collins, J. (2005). Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review. Human Reproduction, 20, 1757-1771. (Pubitemid 40932355)
5. Bosch, E., Vidal, C., Labarta, E., Simon, C., Remohi, J., &Pellicer, A. (2008). Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists - a randomized study. Human Reproduction, 23, 2346-2351.
6. Dell'aquila, M. E., Ambruosi, B., De Santis, T., &Cho, Y. S. (2009). Mitochondrial distribution and activity in human mature oocytes: gonadotropin-releasing hormone agonist versus antagonist for pituitary down-regulation. Fertility and Sterility, 91, 249-255.
7. Erickson, G. F., Wang, C., &Hsueh, A. J. (1979). FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature,May 24, 279(5711), 336-338. (Pubitemid 9179037)
8. Fanchin, R., Righini, C., Olivennes, F., Taieb, J., de Ziegler, D., &Frydman, R. (1999). Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation. Fertility and Sterility, 71, 174-181. (Pubitemid 29042365)
9. Fanchin, R., Righini, C., Ayoubi, J. M., Olivennes, F., de Ziegler, D., &Frydman, R. (2000). New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer. Fertility and Sterility, 74, 274-281. (Pubitemid 30604190)
10. Gómez-Palomares, J. L., Acevedo-Martín, B., Chávez, M., Manzanares, M. A., Ricciarelli, E., &Hernández, E. R. (2008). Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles. Fertility and Sterility, 89, 620-624.
11. Gribbons, B. &Herman, J. (1997). True and quasi-experimental designs. Practical Assessment, Research and Evaluation, 5, 14.
12. M. (2006). GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a metaanalysis. Reproductive Biomedicine Online, 13, 628-638. (Pubitemid 44760885)
13. Golan, A., Ron-el, R., Herman, A., Soffer, Y., Weinraub, Z., &Caspi, E. (1989). Ovarian hyperstimulation syndrome: an update review. Obstetrical and Gynecological Survey, 44, 430-440. (Pubitemid 19138981)
14. Grøndahl, M. L., Borup, R., Lee, Y. B. Myrhøj, V., Meinertz, H., &Sørensen, S. (2009). Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin. Fertility and Sterility, 91, 1820-1830.
15. Hillier, S. G., Zeleznik, A. J., &Ross, G. T. (1978). Independence of steroidogenic capacity and luteinizing hormone receptor induction in developing granulosa cells. Endocrinology, 102, 937-946.
16. Huirne, J. A., Homburg, R., &Lambalk, C. B. (2007). Are GnRH antagonists comparable to agonists for use in IVF? Human Reproduction, 22, 2805-2813. (Pubitemid 351696806)
17. Kilani, Z., Dakkak, A., Ghunaim, S., Cognigni, G. E., Tabarelli, C., Parmegiani, L., et al. (2003). A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes. Human Reproduction, 18, 1194-1199. (Pubitemid 36740563)
18. Koichi, K., Yukiko, N., Shima, K., &Sachiko, S. (2006). Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol. Journal of Assisted Reproduction and Genetics, 23, 223-228. (Pubitemid 43988389)
19. Kolibianakis, E. M., Collins, J., Tarlatzis, B. C., Devroey, P., Diedrich, K., &Griesinger, G. (2006). Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Human Reproduction Update, 12, 651-671. (Pubitemid 44605507)
20. Mochtar, M. H., Van der Veen, F., Ziech, M., &van Wely, M. (2007). Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews, 18, CD005070. (Pubitemid 351805893)
21. Olivennes, F., Cunha-Filho, J. S., Fanchin, R., Bouchard, P., &Frydman, R. (2002). The use of GnRH antagonists in ovarian stimulation. Human Reproduction Update, 8, 279-290. (Pubitemid 34618945)
22. Platteau, P., Andersen, A. N., Balen, A., Devroey, P., Sørensen, P., Helmgaard, L., &Arce, J. C. (2006). Menopur ovulation induction (MOI) study group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Human Reproduction, 21, 1798-1804. (Pubitemid 44028253)
23. Segaloff, D. L., Wang, H. Y., &Richards, J. S. (1990). Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization. Molecular Endocrinology, 4, 1856-1865.
24. Serafini, P., Yadid, I., Motta, E. L., Alegretti, J. R., Fioravanti, J., &Coslovsky, M. (2006). Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Fertility and Sterility, 86, 830-838. (Pubitemid 44485029)
25. Smitz, J., Andersen, A. N., Devroey, P., &Arce, J. C. (2007). Endocrine profile in serum and follicular fluid differs after ovarian stimulation with hp-hMG or recombinant FSH in IVF patients. Human Reproduction, 22, 676-687.
26. Van Wely, M., Westergaard, L. G., Bossuyt, P. M., &Van der Veen, F. (2003). Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews, 1, CD003973. (Pubitemid 37377736)
27. Veeck, L. (1992). Evolución de ovocitos y preembriones en el laboratorio FIV. In Remohi, J., Pellicer, A., &Bonilla Musoles, F., (Eds), Avances en Reproducción Asistida. Madrid: Ediciones Diaz de Santos S.A, 117-162.
28. Weissman, A., Ravhon, A., Biran, G., Levin, D., Golan, A., &Levran, D. (2007). Follicular growth and development under continuous gonadotropin-releasing hormone antagonist administration. Fertility and Sterility, 88, 1677.e15-e17. (Pubitemid 350225710)
29. Westergaard, L. G., Erb, K., Laursen, S. B., Rex, S., &Rasmussen, P. E. (2001). Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropinreleasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertility and Sterility, 76, 543-549. (Pubitemid 32776549)
30. Zeleznik, A. J. &Hillier, S. G. (1984). The role of gonadotropins in the selection of the preovulatory follicle. Clinical Obstetrics and Gynecology, 27, 927-940.
31. Zeleznik, A. J., Midgley, A. R. Jr., &Reichert, L. E. Jr. (1974). Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology, 95, 818- 825.
32. Ziebe, S., Lundin, K., Janssens, R., Helmgaard, L., Arce, J. C.; MERIT (Menotrophin vs. Recombinant FSH in vitro Fertilisation Trial) Group. (2007). Influence of ovarian stimulation with hp-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Human Reproduction, 22, 2404-2413. (Pubitemid 47296603)